// App-Quantinova.ai

DOP18 : OSM neutralisation in IBD mucosal explant cultures reduces pro-inflammatory cytokine production

Researchers

Presenter

  • A Vossenkamper

Principal Investigators

  • K Foster

  • K Nevin

  • G Tannahill

  • S Flint

  • T T McDonald

Medical Centers

  • Blizard Institute, Barts and The London School of Medicine and Dentistry, Centre for Immunobiology, London, UK

  • GlaxoSmithKline, Immunoinflammation Unit, Stevenage, UK

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

  • Gastroenterology (GU)

Disease

  • Ulcerative colitis

  • Crohn's disease

Biomarkers

  • Collagen type IV alpha 2 chain

  • Cytokine

  • Folate Hydrolase 1

Drug/Treatment

  • Prednisolone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved